Re: Clinical Outcomes in Octogenarians Treated with Docetaxel as First-Line Chemotherapy for Castration-Resistant Prostate Cancer.

Authors	Tomas L Griebling
Journal	The Journal of urology (J Urol) Vol. 197 Issue 1 Pg. 155-156 (01 2017) ISSN: 1527-3792 [Electronic] United States
PMID	27979514 (Publication Type: Journal Article, Comment)
Chemical References	Antineoplastic Agents Taxoids Docetaxel Prostate-Specific Antigen
Topics	Aged, 80 and over Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Docetaxel Humans Male Prostate-Specific Antigen Prostatic Neoplasms, Castration-Resistant Taxoids

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!